Education
About Us
Working with TipRanks
Follow Us
Bonus Biogroup (IL:BONS)
:BONS
BONS Stock Chart & Stats
Day’s Range― - ―
52-Week Range9.00 - 23.00
Previous CloseN/A
Volume3.65M
Average Volume (3M)N/A
Market Cap
204.39M
Enterprise ValueN/A
Total Cash (Recent Filing)8.64M
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta0.94
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,167,925,300
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Bonus Biogroup News
PremiumCompany Announcements
Bonus Biogroup Gains FDA Approval for Crucial Phase III ARDS Drug Trial
PremiumCompany Announcements
Court Approves Bonus Biogroup’s Warrant Extension Request---
BONS FAQ
What was Bonus Biogroup ’s price range in the past 12 months?
Bonus Biogroup lowest stock price was 9.00 and its highest was 23.00 in the past 12 months.
What is Bonus Biogroup ’s market cap?
Bonus Biogroup ’s market cap is 204.39M.
When is Bonus Biogroup ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bonus Biogroup ’s earnings last quarter?
Bonus Biogroup released its earnings results on Aug 29, 2021. The company reported -1.6 earnings per share for the quarter, missing the consensus estimate of N/A by -1.6.
Is Bonus Biogroup overvalued?
According to Wall Street analysts Bonus Biogroup ’s price is currently Overvalued.
Does Bonus Biogroup pay dividends?
Bonus Biogroup does not currently pay dividends.
What is Bonus Biogroup ’s EPS estimate?
Bonus Biogroup ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bonus Biogroup have?
Bonus Biogroup has 1,167,925,300 shares outstanding.
What happened to Bonus Biogroup ’s price movement after its last earnings report?
Bonus Biogroup reported an EPS of -1.6 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Bonus Biogroup ?
Currently, no hedge funds are holding shares in IL:BONS
---
Company Description
Bonus Biogroup
Bonus BioGroup Ltd is a biotechnology company. It generates viable tissue-regenerating bone grafts. The company treats skeletal disorders such as bone- and cartilage-related arthritis and various types of bone and joint trauma. It is in the field of tissue engineering, human adipose tissue-derived cells and live bone transplantation.
---
Technical Analysis
---